New tenofovir formulation works equally well with less effect on kidneys and bones
Raltegravir is a good choice for people with HIV undergoing cancer chemotherapy
High prevalence of heart rhythm disturbance among HIV-positive people on methadone maintenance therapy
Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
Reduced efavirenz dose suppresses HIV as well as standard dose
